MyAverix Finance
SHG · Healthcare
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811)
Drug Manufacturers - Specialty & Generic
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $3.94B, P/E ratio is 17.19, net margin is 28.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603811
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) — FAQ
What is Zhejiang Cheng Yi Pharmaceutical Co Ltd's market cap?
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a reported market cap of $3.94B (data as of 2026-03-29).
What is 603811's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) is 17.19 (data as of 2026-03-29).
Does Zhejiang Cheng Yi Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang Cheng Yi Pharmaceutical Co Ltd in?
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603811 listed on?
603811 is listed on SHG.
What is Zhejiang Cheng Yi Pharmaceutical Co Ltd's net margin?
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) reports a net margin of 28.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.